Palisade Bio 대차 대조표 상태
재무 상태 기준 확인 6/6
Palisade Bio has a total shareholder equity of $9.9M and total debt of $349.0K, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are $12.9M and $2.9M respectively.
주요 정보
3.5%
부채 비율
US$349.00k
부채
이자 보상 비율 | n/a |
현금 | US$11.35m |
주식 | US$9.95m |
총 부채 | US$2.92m |
총 자산 | US$12.87m |
최근 재무 상태 업데이트
Recent updates
Palisade Bio announces CEO transition
Oct 11Palisade Bio streamlines operations, including cutting 20% of employees
Sep 15Palisade Bio GAAP EPS of -$0.12
Aug 15Palisade Bio begins phase 3 study testing LB1148 for postoperative return of bowel function
Jul 27Palisade Bio rises 10% after starting phase 3 study of gastrointestinal surgery therapy
Jun 29Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely
Mar 28Palisade Bio: Guarding Intestinal Integrity
Nov 07재무 상태 분석
단기부채: PALI's short term assets ($12.3M) exceed its short term liabilities ($2.8M).
장기 부채: PALI's short term assets ($12.3M) exceed its long term liabilities ($86.0K).
부채 대 자본 내역 및 분석
부채 수준: PALI has more cash than its total debt.
부채 감소: PALI had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: PALI has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.
예측 현금 활주로: PALI is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.